NewAmsterdam Pharma Company NV (NAMS)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current NAMS market cap is 1.39B. The company's latest EPS is USD -1.9656 and P/E is -7.87.
| Quarter End | Mar 2024 | Jun 2024 |
|---|---|---|
| USD ($) | ||
| Total Revenue | 1.4M | 2.28M |
| Operating Income | -55.48M | -52.58M |
| Net Income | -93.77M | -39.01M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Revenue | 14.09M |
| Operating Income | -182.69M |
| Net Income | -176.94M |
| Quarter End | Mar 2024 | Jun 2024 |
|---|---|---|
| USD ($) | ||
| Total Assets | 488.46M | 446.69M |
| Total Liabilities | 76.66M | 59.25M |
| Total Equity | 411.8M | 387.44M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Assets | 347.1M |
| Total Liabilities | 58.7M |
| Total Equity | 288.39M |
| Market Cap | 1.39B |
| Price to Earnings Ratio | -7.87 |
| Price to Sales Ratio | 98.85 |
| Price to Cash Ratio | 4.09 |
| Price to Book Ratio | 4.83 |
| Dividend Yield | - |
| Shares Outstanding | 90.02M |
| Average Volume (1 week) | 252.07k |
| Average Volume (1 Month) | 243.99k |
| 52 Week Change | 66.88% |
| 52 Week High | 26.35 |
| 52 Week Low | 5.6326 |
| Spread (Intraday) | 9.44 (38.14%) |
| Company Name | NewAmsterdam Pharma Company NV |
| Address |
gooimeer 2-35 naarden, north holland 1411 DC |
| Website | https://www.newamsterdampharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
